The erythropoietin receptor and the molecular basis of signal transduction
- PMID: 1485183
The erythropoietin receptor and the molecular basis of signal transduction
Similar articles
-
Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor.Leukemia. 1997 Apr;11 Suppl 3:432-4. Leukemia. 1997. PMID: 9209415
-
Deregulation of erythropoiesis by the Friend spleen focus-forming virus.Int J Biochem Cell Biol. 1999 Oct;31(10):1089-109. doi: 10.1016/s1357-2725(99)00074-6. Int J Biochem Cell Biol. 1999. PMID: 10582341 Review.
-
Pathogenesis of Friend leukemia virus.Leukemia. 1997 Apr;11 Suppl 3:152-4. Leukemia. 1997. PMID: 9209327
-
Friend erythroleukemia revisited.Blood. 2000 Dec 1;96(12):3675-80. Blood. 2000. PMID: 11090047 Review. No abstract available.
-
The erythropoietin receptor: dimerization, activation, and tumorigenesis.Cold Spring Harb Symp Quant Biol. 1992;57:95-106. doi: 10.1101/sqb.1992.057.01.013. Cold Spring Harb Symp Quant Biol. 1992. PMID: 1339709 No abstract available.
Cited by
-
Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms.Biochem J. 1996 Jan 15;313 ( Pt 2)(Pt 2):391-9. doi: 10.1042/bj3130391. Biochem J. 1996. PMID: 8573070 Free PMC article.
-
The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation.Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6849-53. doi: 10.1073/pnas.90.14.6849. Proc Natl Acad Sci U S A. 1993. PMID: 8341708 Free PMC article.
-
Murine pluripotent hematopoietic progenitors constitutively expressing a normal erythropoietin receptor proliferate in response to erythropoietin without preferential erythroid cell differentiation.Mol Cell Biol. 1994 Jul;14(7):4834-42. doi: 10.1128/mcb.14.7.4834-4842.1994. Mol Cell Biol. 1994. PMID: 8007982 Free PMC article.
-
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.PLoS One. 2010 Aug 5;5(8):e12015. doi: 10.1371/journal.pone.0012015. PLoS One. 2010. Retraction in: PLoS One. 2020 Mar 4;15(3):e0230279. doi: 10.1371/journal.pone.0230279. PMID: 20700488 Free PMC article. Retracted.